December 10, 2012
Drug company Novartis is betting $20 million on a cancer treatment that seems to have saved a little girl’s life, according to a report from The New York Times’ Denise Grady.
Just last spring, six-year-old leukemia victim Emma Whitehead was “near death,” having gone through chemotherapy twice without success.
But then her parents put Emma through an experimental treatment at Childrenâ€™s Hospital of Philadelphia.
They infected her with a version of HIV, reprogrammed to attack cancer cells.